The European Union wants to eliminate from municipal wastewater drug residues excreted by people who need to take them. This is to be financed by the pharmaceutical industry. - This is a huge expense for manufacturers of inexpensive drugs, which will result in an increase in the cost of their manufacture and a decrease in availability, reports Krzysztof Kopeć, president of the National Drug Manufacturers. Today (Nov. 5), the Council will decide on the adoption of a directive on urban wastewater treatment. The Polish government opposes these regulations in the interest of patients.
Drug manufacturers are obliged to follow sound production wastewater management practices. Companies closely monitor and eliminate pollutants discharged from their plants. Trace chemical residues of drugs found in wastewater within the EU are the result of human consumption. Chemical pollution is also generated by other sectors.
Under the directive's proposed principle of extended producer responsibility, manufacturers of...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
